Empowering Women and Children: A Tech-Driven Approach to End GBV
The 16 Days of Activism for No Violence Against Women and Children Campaign (16 Days Campaign) is a United Nations initiative held annually from 25 November (International Day for the Elimination of Violence Against Women) to early December.
As we conclude the 16 Days of Activism for No Violence Against Women and Children Campaign for 2024, under the theme: “30 Years of Advancing Collective Action to End Violence Against Women and Children,” Mediwell—a women-inspired company and one of the most women-empowered organizations—has sought to leverage technological innovation to combat the scourge of gender-based violence (GBV).
A digital platform has been developed to address GBV comprehensively, although it is currently at the Minimum Viable Product (MVP) stage. To scale this platform to its full potential, Mediwell seeks collaboration with funders and tech companies to advance and enhance its capacity to mitigate GBV. The platform aims to provide an integrated approach to preventive, proactive, and supportive GBV care for women and children.
Dr. Maggie Mojapelo, founder of Mediwell, reflects:
“I have led and participated in countless marches over the past 30 years. I believe the time has come to adopt additional strategies, including tech innovations, to tackle GBV. As doctors and medics, we constantly witness the devastating aftermath of GBV—burns, bruises, abrasions, near strangulation, emotional and mental trauma, and in the worst cases, fatalities such as suicide and death. These tragedies have become all too frequent in recent months and years.”
In line with the theme of advancing collective action to end violence against women and children, the time to act is now. Together, we must execute impactful solutions to eradicate this scourge on women and children once and for all.
For those who wish to collaborate with us in advancing this initiative, please reach out via email at admin@mediwell.co.za, visit our website at www.mediwell.co.za, or call us at 011 300 2900.
